Literature DB >> 11350903

Expression of MUC1 mucins in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder.

T Kawamoto1, J Shoda, T Irimura, N Miyahara, M Furukawa, T Ueda, T Asano, M Kano, N Koike, K Fukao, N Tanaka, T Todoroki.   

Abstract

The overall outcome of pT(2) gallbladder carcinoma has not been favorable. Postsurgical recurrence at distant sites occurs in some cases, although the carcinoma was limited to the gallbladder wall. A high level expression of MUC1 mucins with sialylated carbohydrates (sialylated MUC1 mucins) is correlated with poor survival in intrahepatic bile duct carcinoma. In the present study, immunohistochemistry was performed to determine the expression level of sialylated MUC1 mucins, detected by a monoclonal antibody, MY.1E12, in 31 cases of pT(2) gallbladder carcinoma on which curative resections had been performed and to determine the correlation of the expression level of MY.1E12-reactive-MUC1 mucin with mode of recurrence and postsurgical survival. Immunostainings of the MUC1 mucin were recognized in different types of noncancerous pathological epithelia of the gallbladder except for intestinal metaplasia and cancerous epithelia. Immunohistochemical localization was classified into apical, cytoplasmic, and stromal types based on the predominant cellular distribution of MY.1E12-reactive-MUC1 mucin. In 31 cases of pT(2) carcinoma, the localization was apical type in 64%, cytoplasmic type in 71%, and stromal type in 48% of the cases at the deepest invading sites in the subserosal layer. Distant recurrences, i.e., peritoneal dissemination in 8 patients and liver metastasis in 3 patients, were seen in 8 (53%) of 15 cases of pT(2) carcinoma that had > or =10% of the cancerous epithelia showing stromal localization of the MUC1 mucin at the deepest invading sites and in 2 (12%) of 16 cases that had <10% of those showing the stromal localization. The postsurgical survival outcome was significantly poorer in the former than in the latter (P = 0.044). In pT(2) gallbladder carcinoma, the presence of MY.1E12-reactive-MUC1 mucin in the stroma adjacent to the cancerous epithelia in the subserosal layer correlates with the aggressiveness of the disease, such as the tendency to form distant recurrences. This phenotype may serve as a unique biological feature associated with the malignant behavior of pT(2) gallbladder carcinoma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11350903

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  9 in total

1.  MUC1 and MUC5AC mucin expression in liver fluke-associated intrahepatic cholangiocarcinoma.

Authors:  Chanchai Boonla; Banchob Sripa; Peti Thuwajit; Ubon Cha-On; Anucha Puapairoj; Masanao Miwa; Sopit Wongkham
Journal:  World J Gastroenterol       Date:  2005-08-28       Impact factor: 5.742

2.  Expression of MUC1 recognized by a monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of carcinoma of the gallbladder.

Authors:  Toru Kawamoto; Junichi Shoda; Naoki Miyahara; Hideo Suzuki; Masato Furukawa; Takeshi Todoroki; Naomi Tanaka; Tatsuro Irimura
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

3.  Expression of MUC1 recognized by monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of advanced colon carcinoma.

Authors:  Hideo Suzuki; Junichi Shoda; Toru Kawamoto; Eiji Shinozaki; Naoki Miyahara; Souichi Hotta; Yasushi Iizuka; Akira Nakahara; Naomi Tanaka; Akinori Yanaka; Tatsuro Irimura
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

4.  Expression of N-acetylglucosaminyltransferase V in the subserosal layer correlates with postsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder.

Authors:  Kenichiro Onuki; Hiroaki Sugiyama; Kazunori Ishige; Toru Kawamoto; Takehiro Ota; Shunichi Ariizumi; Masayuki Yamato; Shinichi Kadota; Kaoru Takeuchi; Akiko Ishikawa; Masafumi Onodera; Kojiro Onizawa; Masakazu Yamamoto; Eiji Miyoshi; Junichi Shoda
Journal:  J Gastroenterol       Date:  2013-04-17       Impact factor: 7.527

5.  Significance of PML and p53 protein as molecular prognostic markers of gallbladder carcinomas.

Authors:  Hee Jin Chang; Byong Chul Yoo; Sun Whe Kim; Byung Lan Lee; Woo Ho Kim
Journal:  Pathol Oncol Res       Date:  2007-12-25       Impact factor: 3.201

6.  Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter study.

Authors:  Junichi Shoda; Atsushi Matsuda; Takashi Shida; Masakazu Yamamoto; Masato Nagino; Toshio Tsuyuguchi; Takahiro Yasaka; Susumu Tazuma; Kazuhisa Uchiyama; Michiaki Unno; Nobuaki Ohkohchi; Yasuni Nakanuma; Atsushi Kuno; Hisashi Narimatsu
Journal:  J Gastroenterol       Date:  2016-06-29       Impact factor: 7.527

7.  Gallbladder cancer detected by elevated serum KL-6 levels during the follow-up of interstitial pneumonia: a case report.

Authors:  Yoshikuni Yonenaga; Manabu Kurosawa; Shunichi Higashide
Journal:  Int Cancer Conf J       Date:  2021-01-03

8.  Clinical significance of immune cell infiltration within gallbladder cancer.

Authors:  Y Nakakubo; M Miyamoto; Y Cho; Y Hida; T Oshikiri; M Suzuoki; K Hiraoka; T Itoh; S Kondo; H Katoh
Journal:  Br J Cancer       Date:  2003-11-03       Impact factor: 7.640

9.  Functional and genomic characterization of three novel cell lines derived from a metastatic gallbladder cancer tumor.

Authors:  Patricia García; Carolina Bizama; Lorena Rosa; Jaime A Espinoza; Helga Weber; Javier Cerda-Infante; Marianela Sánchez; Viviana P Montecinos; Justo Lorenzo-Bermejo; Felix Boekstegers; Marcela Dávila-López; Francisca Alfaro; Claudia Leiva-Acevedo; Zasha Parra; Diego Romero; Sumie Kato; Pamela Leal; Marcela Lagos; Juan Carlos Roa
Journal:  Biol Res       Date:  2020-04-15       Impact factor: 5.612

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.